Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bioray Biotech Co., Ltd. (7561:TWSE), powered by AI.
Bioray Biotech Co., Ltd. is currently trading at $18.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bioray Biotech Co., Ltd. on Alpha Lenz.
View Bioray Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.
“Bioray Biotech Co., Ltd.'s ROE is 7.4%. Explore profitability and growth together.”
Ask for details →Bioray Biotech Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and sale of biological and health supplement products. Founded in 1994 and headquartered in Pingtung, Taiwan, Bioray stands out for its focus on innovative health solutions, including functional probiotics, medicinal fungi, immune cell preparations, and advanced cell testing and storage services. The company’s portfolio supports sectors such as healthcare, drug manufacturing, and biotechnology, with offerings that range from raw material production and probiotic capsules to immune function and cancer precision medicine testing. Its cell storage business is geared toward stem and immune cell preservation, as well as cytokine-based therapies, positioning Bioray Biotech at the intersection of preventive health and personalized medicine. With a market capitalization in the hundreds of millions TWD and a broad float, Bioray serves both institutional and individual clients, contributing to Taiwan’s thriving biotech sector and the global life sciences industry through its emphasis on product quality and scientific innovation.
“Bioray Biotech Co., Ltd.'s ROE is 7.4%. Explore profitability and growth together.”
Ask for details →Bioray Biotech Co., Ltd. (ticker: 7561) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 76 employees.
The current price is 18.2 with a P/E ratio of -x and P/B of -x.
ROE is 7.38% and operating margin is 16.97%. Annual revenue is $223M.